Pioneering new frontiers in circadian medicine chronotherapies for cardiovascular health.

Journal: Trends in endocrinology and metabolism: TEM

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  Centre for Cardiovascular Investigations, University of Guelph; Guelph, Ontario, Canada; Department of Biomedical Sciences, University of Guelph; Guelph, Ontario, Canada. Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia. Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX, USA. Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX, USA; Department of Internal Medicine, Division of Cardiology, McGovern School of Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. Department of Biomedical Sciences, University of Guelph; Guelph, Ontario, Canada. Centre for Cardiovascular Investigations, University of Guelph; Guelph, Ontario, Canada; Department of Biomedical Sciences, University of Guelph; Guelph, Ontario, Canada. Electronic address: tmartino@uoguelph.ca.

Abstract summary 

Cardiovascular disease (CVD) is a global health concern. Circadian medicine improves cardiovascular care by aligning treatments with our body's daily rhythms and their underlying cellular circadian mechanisms. Time-based therapies, or chronotherapies, show special promise in clinical cardiology. They optimize treatment schedules for better outcomes with fewer side effects by recognizing the profound influence of rhythmic body cycles. In this review, we focus on three chronotherapy areas (medication, light, and meal timing) with potential to enhance cardiovascular care. We also highlight pioneering research in the new field of rest, the gut microbiome, novel chronotherapies for hypertension, pain management, and small molecules that targeting the circadian mechanism.

Authors & Co-authors:  Festus Spilberg Young Cain Khoshnevis Smolensky Zaheer Descalzi Martino

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  9
Identifiers
Doi : S1043-2760(24)00040-7
SSN : 1879-3061
Study Population
Male,Female
Mesh Terms
Other Terms
cardiovascular disease;chronotherapy;circadian biology;feeding/fasting;heart clock;hypertension;light;rest
Study Design
Study Approach
Country of Study
Publication Country
United States